METLIFE INC

MET· NYSE, NYSE, NYSE, NYSE· Life Insurance

Market cap
–
P/FCF
–
EV/Sales
–
FCF margin
–
ROIC, 5 yr avg
–
Revenue, 5 yr CAGR
+12.5%
We record prices for the companies we cover; MET is not one of them yet.

Company statistics

From the 10-Ks, computed in code · point at a figure for its formula

Profile · FY2025

Market cap
–
Enterprise value
–
Diluted shares
673.3M
Revenue
$2.4B
Free cash flow
–
Owner earnings
–

Valuation · FY2025

P/E
–
P/FCF
–
P/Owner earnings
–
EV/Sales
–
EV/FCF
–
P/B
–

Margins · FY2025

Gross
–
Operating
251.9%
Net
138.7%
Free cash flow
–
Owner earnings
–
Stock pay
5.4%

Returns

ROIC, FY2025
–
ROIC, 5 yr avg
–
ROE, FY2025
11.9%
ROE, 5 yr avg
12.2%

Growth (CAGR)

Revenue, 3 yr
4.9%
Revenue, 5 yr
12.5%
Revenue, 9 yr
-30.1%
Diluted EPS, 3 yr
-9.2%
Diluted EPS, 5 yr
-3.7%
Diluted EPS, 9 yr
24.2%
Free cash flow, 3 yr
–
Free cash flow, 5 yr
–
Free cash flow, 9 yr
–

Financial health · FY2025

Cash and investments
$25.6B
Total debt
–
Net cash
–
Debt/Equity
–
Debt/FCF
–

Shareholder returns · FY2025

Dividend yield
–
Payout ratio
44.7%
Buyback yield
–
Shareholder yield
–
Share count, 5 yr
-5.9%

Financials: ten years from the 10-Ks

Reported numbers open their filing · computed ones show the formula · ˢ split-adjusted

Revenue

$2.4B

-30.1% a year over 9 years

FY2016: Revenue $60.8BFY2017: Revenue $62.3BFY2018: Revenue $1.3BFY2019: Revenue $1.3BFY2020: Revenue $1.4BFY2021: Revenue $2.1BFY2022: Revenue $2.1BFY2023: Revenue $2.2BFY2024: Revenue $2.2BFY2025: Revenue $2.4B
FY2016FY2025

Margins

Operating251.9%Net138.7%

FY2025

FY2016: Operating –, Net 1.4%FY2017: Operating –, Net 6.4%FY2018: Operating –, Net 407.9%FY2019: Operating –, Net 457.6%FY2020: Operating –, Net 399.3%FY2021: Operating –, Net 330.5%FY2022: Operating 283.3%, Net 250.4%FY2023: Operating 256.8%, Net 70.8%FY2024: Operating 267.1%, Net 197.1%FY2025: Operating 251.9%, Net 138.7%
FY2016FY2025

Diluted shares

673.3M

-39.3% over 9 years, net buybacks

FY2016: Diluted shares 1.11BFY2017: Diluted shares 1.08BFY2018: Diluted shares 1.01BFY2019: Diluted shares 944.4MFY2020: Diluted shares 913.2MFY2021: Diluted shares 869.4MFY2022: Diluted shares 808.9MFY2023: Diluted shares 762.3MFY2024: Diluted shares 711.1MFY2025: Diluted shares 673.3M
FY2016FY2025

Every figure, year by year

Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
The business
Revenue$60.8B$62.3B$1.3B$1.3B$1.4B$2.1B$2.1B$2.2B$2.2B$2.4B
Revenue growth-0.9%2.5%-98.0%2.6%5.0%53.2%1.7%5.6%0.7%8.5%
Gross margin––––––––––
Operating margin––––––283.3%256.8%267.1%251.9%
Net income$850.0M$4.0B$5.1B$5.9B$5.4B$6.9B$5.3B$1.6B$4.4B$3.4B
Net margin1.4%6.4%407.9%457.6%399.3%330.5%250.4%70.8%197.1%138.7%
Diluted EPS$0.67$3.62$4.91$6.06$5.68$7.65$6.30$1.81$5.94$4.71
Return on invested capital?––––––––––
Cash
Operating cash flow$14.8B$12.3B$11.7B$13.8B$11.6B$12.3B$13.0B$13.7B$14.6B$17.1B
Capital expenditure––––––––––
Free cash flow––––––––––
Stock-based compensation$147.0M$128.0M$86.0M$150.0M$127.0M$173.0M$184.0M$171.0M$168.0M$131.0M
Owner earnings?––––––––––
Free cash flow per share––––––––––
Capital allocation
Dividends paid$1.7B$1.7B$1.7B$1.6B$1.7B$1.6B$1.6B$1.6B$1.5B$1.5B
Share repurchases$372.0M$2.9B$4.0B$2.3B$1.2B$4.3B$3.3B$3.1B$3.2B$2.9B
Diluted shares1.11B1.08B1.01B944.4M913.2M869.4M808.9M762.3M711.1M673.3M
Share count change?-1.8%-2.7%-6.0%-6.9%-3.3%-4.8%-7.0%-5.8%-6.7%-5.3%
Balance sheet
Cash and equivalents$12.7B$12.7B$15.8B$16.6B$19.8B$20.0B$20.2B$20.6B$20.1B$22.0B
Short-term investments$6.5B$4.9B$3.9B$3.9B$3.9B$7.2B$4.9B$6.0B$5.2B$3.6B
Total debt––––––––––
Net debt––––––––––
Shareholders' equity$67.5B$58.7B$52.7B$66.1B$74.6B$67.5B$29.9B$30.0B$27.4B$28.4B

Latest filings

All on EDGAR
2026-08-0610-QQuarterly report
2026-08-058-KEarnings release
2026-05-0710-QQuarterly report
2026-05-068-KEarnings release
2026-04-29DEF 14AProxy statement
2026-02-1910-KAnnual report
2026-02-048-KEarnings release
2025-11-0710-QQuarterly report
2025-11-058-KEarnings release
2025-08-0710-QQuarterly report

More from our coverage

All coverage